The cell kinetics of human mammary cancers

L. M. Schiffer, Paul G Braunschweiger, J. J. Stragand, L. Poulakos

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The cellular kinetics of human mammary tumors were studied by in vitro methods. These techniques include single 3HTdR labeling to measure the 3HTdR labeling index (LI), double labeling with 3HTdR and 14CTdR to measure DNA synthesis time, and an estimation of the growth fraction by the primer available DNA polymerase assay (PDP index.) Calculations of the potential doubling time and cell cycle time were made from these measurements. The 3HTdR LI of primary malignant tumors was greater than that of benign tumors, but only half that of metastatic lesions. There was considerable heterogeneity in the 3HTdR LI of primary tumors, but the DNA synthesis times were relatively invariant. Estimation of the growth fraction by the PDP index also revealed extensive heterogeneity, but the primary tumors were not different from metastases. There appear to be subsets of tumors with high and low proliferative values that correlate with some clinical parameters, such as age and nodal positivity. This material provides a data base for stratification of patients for future protocols and the use of cell kinetics in treatment programs.

Original languageEnglish
Pages (from-to)1707-1719
Number of pages13
JournalCancer
Volume43
Issue number5
StatePublished - Dec 1 1979
Externally publishedYes

Fingerprint

Breast Neoplasms
Neoplasms
DNA
DNA-Directed DNA Polymerase
Growth
Cell Cycle
Databases
Neoplasm Metastasis
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Schiffer, L. M., Braunschweiger, P. G., Stragand, J. J., & Poulakos, L. (1979). The cell kinetics of human mammary cancers. Cancer, 43(5), 1707-1719.

The cell kinetics of human mammary cancers. / Schiffer, L. M.; Braunschweiger, Paul G; Stragand, J. J.; Poulakos, L.

In: Cancer, Vol. 43, No. 5, 01.12.1979, p. 1707-1719.

Research output: Contribution to journalArticle

Schiffer, LM, Braunschweiger, PG, Stragand, JJ & Poulakos, L 1979, 'The cell kinetics of human mammary cancers', Cancer, vol. 43, no. 5, pp. 1707-1719.
Schiffer LM, Braunschweiger PG, Stragand JJ, Poulakos L. The cell kinetics of human mammary cancers. Cancer. 1979 Dec 1;43(5):1707-1719.
Schiffer, L. M. ; Braunschweiger, Paul G ; Stragand, J. J. ; Poulakos, L. / The cell kinetics of human mammary cancers. In: Cancer. 1979 ; Vol. 43, No. 5. pp. 1707-1719.
@article{3fdc4fae271748dcbc884450bb79dc52,
title = "The cell kinetics of human mammary cancers",
abstract = "The cellular kinetics of human mammary tumors were studied by in vitro methods. These techniques include single 3HTdR labeling to measure the 3HTdR labeling index (LI), double labeling with 3HTdR and 14CTdR to measure DNA synthesis time, and an estimation of the growth fraction by the primer available DNA polymerase assay (PDP index.) Calculations of the potential doubling time and cell cycle time were made from these measurements. The 3HTdR LI of primary malignant tumors was greater than that of benign tumors, but only half that of metastatic lesions. There was considerable heterogeneity in the 3HTdR LI of primary tumors, but the DNA synthesis times were relatively invariant. Estimation of the growth fraction by the PDP index also revealed extensive heterogeneity, but the primary tumors were not different from metastases. There appear to be subsets of tumors with high and low proliferative values that correlate with some clinical parameters, such as age and nodal positivity. This material provides a data base for stratification of patients for future protocols and the use of cell kinetics in treatment programs.",
author = "Schiffer, {L. M.} and Braunschweiger, {Paul G} and Stragand, {J. J.} and L. Poulakos",
year = "1979",
month = "12",
day = "1",
language = "English",
volume = "43",
pages = "1707--1719",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - The cell kinetics of human mammary cancers

AU - Schiffer, L. M.

AU - Braunschweiger, Paul G

AU - Stragand, J. J.

AU - Poulakos, L.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - The cellular kinetics of human mammary tumors were studied by in vitro methods. These techniques include single 3HTdR labeling to measure the 3HTdR labeling index (LI), double labeling with 3HTdR and 14CTdR to measure DNA synthesis time, and an estimation of the growth fraction by the primer available DNA polymerase assay (PDP index.) Calculations of the potential doubling time and cell cycle time were made from these measurements. The 3HTdR LI of primary malignant tumors was greater than that of benign tumors, but only half that of metastatic lesions. There was considerable heterogeneity in the 3HTdR LI of primary tumors, but the DNA synthesis times were relatively invariant. Estimation of the growth fraction by the PDP index also revealed extensive heterogeneity, but the primary tumors were not different from metastases. There appear to be subsets of tumors with high and low proliferative values that correlate with some clinical parameters, such as age and nodal positivity. This material provides a data base for stratification of patients for future protocols and the use of cell kinetics in treatment programs.

AB - The cellular kinetics of human mammary tumors were studied by in vitro methods. These techniques include single 3HTdR labeling to measure the 3HTdR labeling index (LI), double labeling with 3HTdR and 14CTdR to measure DNA synthesis time, and an estimation of the growth fraction by the primer available DNA polymerase assay (PDP index.) Calculations of the potential doubling time and cell cycle time were made from these measurements. The 3HTdR LI of primary malignant tumors was greater than that of benign tumors, but only half that of metastatic lesions. There was considerable heterogeneity in the 3HTdR LI of primary tumors, but the DNA synthesis times were relatively invariant. Estimation of the growth fraction by the PDP index also revealed extensive heterogeneity, but the primary tumors were not different from metastases. There appear to be subsets of tumors with high and low proliferative values that correlate with some clinical parameters, such as age and nodal positivity. This material provides a data base for stratification of patients for future protocols and the use of cell kinetics in treatment programs.

UR - http://www.scopus.com/inward/record.url?scp=0018743208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018743208&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 1707

EP - 1719

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -